Answers are grounded in this paper and cite their sources.
Critical-size bone defects remain a major clinical challenge, as impaired endogenous healing and an unfavorable local microenvironment prevent spontaneous bridging of the defect. Here, we report a bio-physical regenerative strategy that combines a three-dimensional, porous alginate–chitosan/hydroxyapatite (Alg-CS/HA) nanocomposite scaffold with targeted pulsed electromagnetic field (PEMF) stimulation. Rod-like hydroxyapatite (HA) nanoparticles (~12 × 86 nm, Ca/P = 1.64) were synthesized and incorporated at 30 wt% into an ionically crosslinked Alg-CS polyelectrolyte matrix. HA incorporation significantly increased the compressive strength (22.41 ± 1.35 vs. 14.53 ± 1.81 kPa) and modulus (156.51 ± 2.15 vs. 74.34 ± 1.43 kPa) of the scaffold, while preserving an interconnected porous architecture (75.97 ± 7.8% porosity) and slowing enzymatic biodegradation (76.70 ± 3.82% mass loss at 28 days). MTT assays on human skin fibroblasts confirmed that both formulations were highly cytocompatible, with viability exceeding 85% at concentrations up to 50 mg/mL. In vivo, bilateral critical-size femoral defects (6 mm diameter) were created in New Zealand rabbits to evaluate bone regeneration under two PEMF regimes (5 and 50 Hz; 0.22 and 0.5 mT) applied for 3 weeks. Untreated defects showed essentially no repair (1.0 ± 2.4%), whereas scaffold implantation alone yielded 20.0 ± 4.3% new bone formation. PEMF stimulation produced a clear frequency- and intensity-dependent enhancement of osteogenesis, culminating in 90.0 ± 5.2% defect bridging in the low-frequency, high-intensity group (5 Hz, 0.5 mT), a 4.5-fold increase over the scaffold-only control. Histological analysis showed dense, mature trabecular bone with abundant osteocytes, active osteoid deposition, and histological features consistent with vascularization in this group. These preliminary results were obtained with n = 3 defect sites per group. Together, they suggest that coupling an Alg-CS/HA nanocomposite scaffold with low-frequency, high-intensity PEMF stimulation is a promising, non-invasive strategy for enhancing the repair of critical-size bone defects, warranting confirmation in larger studies.
No takes yet. Share an insight, caveat, or question.
El‐Fattah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: